What does Adial Pharmaceuticals, Inc. do?
Adial Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment or prevention of addiction and related disorders. The company's lead product is AD04, a serotonin-3 antagonist, which is in Phase 3 clinical trials for the treatment of alcohol use…
What is Adial Pharmaceuticals, Inc.'s P/E and P/B ratio?
Adial Pharmaceuticals, Inc. has a P/E ratio of -0.2 and a P/B ratio of -0.29.
What is Adial Pharmaceuticals, Inc.'s debt-to-equity ratio?
Adial Pharmaceuticals, Inc. has a debt-to-equity ratio of 0.00.
How much does Adial Pharmaceuticals, Inc. owe compared with what it owns?
Adial Pharmaceuticals, Inc. owes $2.32 for every $1 it owns (balance sheet Jun 2026), which means it owes more than it owns.
What is Adial Pharmaceuticals, Inc.'s Positivity rank?
Adial Pharmaceuticals, Inc. is ranked #6,451 of 6,774 companies globally and #3,710 of 4,000 in United States on PositoAI, with a Positivity Score of -19,883.
Does Adial Pharmaceuticals, Inc. have any regulatory orders, red flags (PosiRed) or yellow flags (PosiYellow)?
Yes. Adial Pharmaceuticals, Inc. has 1 active red flag (PosiRed) on record: Stock exchange listing-rule deficiency notice (8-K Item 3.01) (dated 21 Aug 2026). It has no yellow flags.
Where can I read the latest news about Adial Pharmaceuticals, Inc.?
Recent headlines about Adial Pharmaceuticals, Inc. from the last 30 days, with links to the original articles, are on its News page on PositoAI.
Does Adial Pharmaceuticals, Inc. have a PositoAI PosiShot or QR code?
Yes. A dated PosiShot of Adial Pharmaceuticals, Inc.'s current position, a PosiQR code for its live profile and a ready-made dated mention are available on its For this company page on PositoAI.